Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aramis Biotechnologies
Quebec City*, Quebec, Canadaaramisbiotechnologies.com ↗
- Ownership
- Private
- Employees
- ~51
- Development stage
- Preclinical
01
Overview
Aramis Biotechnologies is developing a next-generation plant-based biomanufacturing platform to produce vaccines and therapeutics. Its lead program is a seasonal influenza vaccine currently at the preclinical stage. The company secured key assets from Medicago—including its technology platform and pilot facility—in late 2023. With significant Canadian government investment ($40 million), Aramis aims to advance its influenza vaccine into clinical trials and expand applications of its proprietary plant-derived biologics technology.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Plant-based biologics/vaccinesProphylactic vaccines
- Industry
- Biotech
02
Partnerships
Government of Canada (major funding partner)Inherits legacy partnerships/assets from Medicago but no direct pharma partnerships disclosed yet.
Beyond the preview
Go deeper on Aramis Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aramis Biotechnologies.